Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Karlsson

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trialDan Lundstedt, Magnus Gustafsson, Per Malmström, et al.
Psychopharmacology|January 15, 2011
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369Katarina Varnäs, Svante Nyberg, Per Karlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trialAglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
EJNMMI Research|December 5, 2025
Automatic volumetric estimates of the left and right atrium using dynamic PETHendrik J Harms, Bent Roni Nielsen, Tanja Kero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2003
[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brainChrister Halldin, Nina Erixon-Lindroth, Stefan Pauli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
BMJ Open|September 26, 2023
Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trialSara Alkner, Jana de Boniface, Dan Lundstedt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT TrialFredrika Killander, Elinore Wieslander, Per Karlsson, et al.
Oncotarget|November 13, 2018
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survivalHanna Engqvist, Toshima Z Parris, Elisabeth Werner Rönnerman, et al.
JAMA Network Open|April 3, 2026
Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 CarriersRebecca Wiberg, Signe Hägglund, Barbro Numan Hellquist, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trialDan Lundstedt, Magnus Gustafsson, Per Malmström, et al.
Psychopharmacology|January 15, 2011
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369Katarina Varnäs, Svante Nyberg, Per Karlsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trialAglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
EJNMMI Research|December 5, 2025
Automatic volumetric estimates of the left and right atrium using dynamic PETHendrik J Harms, Bent Roni Nielsen, Tanja Kero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 18, 2003
[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brainChrister Halldin, Nina Erixon-Lindroth, Stefan Pauli, et al.
International Journal of Radiation Oncology, Biology, Physics|August 24, 2010
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyPer Karlsson, Bernard F Cole, Marco Colleoni, et al.
BMJ Open|September 26, 2023
Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trialSara Alkner, Jana de Boniface, Dan Lundstedt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT TrialFredrika Killander, Elinore Wieslander, Per Karlsson, et al.
Oncotarget|November 13, 2018
Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survivalHanna Engqvist, Toshima Z Parris, Elisabeth Werner Rönnerman, et al.
JAMA Network Open|April 3, 2026
Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 CarriersRebecca Wiberg, Signe Hägglund, Barbro Numan Hellquist, et al.
Pageof 18